{
    "RADCURE-0894": {
        "question": "Age: 79.1, Sex: Female, ECOG PS: ECOG 3, Smoking PY: 0, Smoking Status: Non-smoker, Ds Site: Oropharynx, Subsite: Base of Tongue, T: T4a, N: N2c, M : M0, Stage: IVA, Path: Squamous Cell Carcinoma, HPV: Negative, Tx Modality: RT alone, Chemo? : none, Dose: 60.0, Fx: 25, Local: none, Regional: Yes, Distant: none, 2nd Ca: none, ContrastEnhanced: 1\nAnswer: ",
        "recruit-recruiter": "1. Radiation Oncologist - Your expertise is strictly limited to radiation therapy planning and dosing for head and neck squamous cell carcinoma, especially HPV-negative cases and elderly patients with ECOG PS 3. - Hierarchy: Radiation Oncologist",
        "initial_assessment-radiation oncologist": "Step-by-step analysis as a radiation oncologist:\n\n1. The provided bounding box coordinates are [[235, 150, 82, 235, 219, 109], [235, 150, 82, 235, 219, 109]]. Both bounding boxes are identical, indicating a single region of interest (ROI) within the CT scan.\n\n2. The coordinates are normalized relative to the original image size, but without the original image dimensions, exact anatomical localization is limited. However, the z, y, x ranges suggest a localized volume in the head and neck region.\n\n3. The CT image slice shows a sagittal view of the head and neck. The masked ROI appears to be in the oropharyngeal region, possibly involving the base of tongue or adjacent soft tissues.\n\n4. No obvious gross anatomical abnormalities such as large masses or bone destruction are visible in the provided image slice. The ROI may represent a tumor volume or nodal disease targeted for radiation therapy.\n\n5. From a radiation oncology perspective, the presence of a defined ROI in this region suggests a focus for treatment planning, likely for squamous cell carcinoma of the oropharynx.\n\n6. Without additional clinical data (tumor stage, HPV status, nodal involvement), survival probability cannot be precisely estimated. However, oropharyngeal squamous cell carcinoma, especially if HPV-positive, generally has a favorable prognosis with definitive radiation therapy.\n\n7. The absence of visible distant metastases or gross local invasion in this image slice is a positive sign for local control.\n\nFinal answer: Alive",
        "initial_assessment_review_assessment-radiation oncologist": "Answer:Alive",
        "Round 1-role-comment": "radiation oncologist:alive",
        "Round 1-num_agents": 1,
        "Round 2-Turn 1-discuss-participate_review_assessment-radiation oncologist": "Answer:no",
        "Round 2-Turn 1-ask_gap_review_assessment-radiation oncologist": "---\nAnswer: yes\nReason: Requires ENT surgeon for surgical resectability assessment and medical oncologist for systemic therapy considerations.\n---",
        "Round 2-Turn 1-gap_identified-assistant": "Recommendations for additional consultations:\n\n- ENT surgeon for surgical resectability assessment  \n- Medical oncologist for systemic therapy considerations",
        "Round 2-Turn 1-gap_recruit-recruiter": "1. Medical Oncologist - Your expertise is strictly limited to systemic therapy decisions, including chemotherapy and immunotherapy in head and neck cancers, especially in elderly patients with ECOG PS 3. - Hierarchy: Medical Oncologist == Radiation Oncologist\n2. Surgical Oncologist (Recurrence/Secondary Cancers) - Your expertise is strictly limited to evaluating surgical options and resectability assessment for primary and recurrent head and neck squamous cell carcinoma. - Hierarchy: Surgical Oncologist == Radiation Oncologist",
        "Round 2-Turn 1-gap_recruited_assessment-medical oncologist": "Step-by-step analysis as a medical oncologist:\n\n1. Patient Characteristics:\n   - Age: 79.1 years, which is advanced age and may limit tolerance to aggressive therapy.\n   - ECOG PS 3 indicates significant functional impairment, suggesting poor performance status and limited ability to tolerate intensive treatment.\n\n2. Disease Characteristics:\n   - Primary site: Oropharynx, specifically the base of tongue.\n   - Tumor stage: T4a (locally advanced tumor invading adjacent structures).\n   - Nodal stage: N2c (bilateral or contralateral lymph node involvement).\n   - M0: No distant metastasis.\n   - Stage IVA: Locally advanced disease.\n   - Pathology: Squamous cell carcinoma, HPV negative (generally worse prognosis than HPV positive).\n\n3. Treatment:\n   - Radiation therapy alone (60 Gy in 25 fractions).\n   - No chemotherapy given, likely due to poor performance status.\n   - Regional treatment given, no local or distant treatment beyond RT.\n\n4. Imaging:\n   - The bounding box coordinates correspond to a region in the oropharynx/base of tongue area.\n   - The CT scan shows a masked region of interest likely representing the tumor mass.\n   - No obvious distant metastases or second primary cancers are noted.\n   - The tumor is large and involves regional lymph nodes.\n\n5. Prognostic Considerations:\n   - Advanced age and ECOG 3 predict poor tolerance to aggressive therapy and worse survival.\n   - HPV negative status and T4aN2c stage indicate aggressive disease.\n   - Treatment with RT alone without chemotherapy is suboptimal for this stage but may be the only feasible option given performance status.\n   - Overall, the prognosis is guarded with a high risk of disease progression and mortality.\n\nFinal assessment: Given the advanced stage, poor performance status, and limited treatment, the survival probability is low.\n\nAnswer: Dead",
        "Round 2-Turn 1-gap_recruited_assessment_review_assessment-medical oncologist": "Answer:Dead",
        "Round 2-Turn 1-gap_recruited_assessment-surgical oncologist (recurrence/secondary cancers)": "Step-by-step analysis as a surgical oncologist specializing in recurrence/secondary cancers:\n\n1. The bounding box coordinates provided are identical: [235, 150, 82, 235, 219, 109]. This suggests a very limited or possibly zero-volume region, which may be an error or a very small ROI. The coordinates correspond to a region in the head and neck CT scan, likely around the oropharyngeal area given the context.\n\n2. The image shows a sagittal view of the head and neck with a masked region in the oropharyngeal area, possibly involving the base of tongue or adjacent structures.\n\n3. The patient is elderly (79.1 years), female, with ECOG performance status 3, indicating significant functional impairment.\n\n4. The tumor is T4a (locally advanced), N2c (bilateral lymph node involvement), M0 (no distant metastasis), stage IVA squamous cell carcinoma of the oropharynx, base of tongue subsite.\n\n5. HPV negative status is associated with poorer prognosis compared to HPV positive oropharyngeal cancers.\n\n6. Treatment was radiation therapy alone (60 Gy in 25 fractions), no chemotherapy, which is suboptimal for advanced stage disease.\n\n7. No local or distant recurrence noted at this time, but regional disease was treated.\n\n8. From a surgical oncologist perspective, the advanced T and N stage, poor performance status, HPV negative status, and lack of chemotherapy reduce the likelihood of long-term survival.\n\n9. The masked ROI likely corresponds to the primary tumor or involved lymph nodes, but no clear evidence of resectability or recurrence is provided.\n\n10. Overall, the prognosis is guarded with a high risk of recurrence and mortality.\n\nFinal answer:\n\nAnswer:Dead",
        "Round 2-Turn 1-gap_recruited_assessment_review_assessment-surgical oncologist (recurrence/secondary cancers)": "Answer:Dead",
        "Round 2-Turn 1-Round 2-Turn 1-gap_recruited_discuss-participate_review_assessment-medical oncologist": "Answer:Dead",
        "Round 2-Turn 1-Round 2-Turn 1-gap_recruited_discuss-participate_review_assessment-surgical oncologist (recurrence/secondary cancers)": "Answer:Dead",
        "Round 2-role-comment": "radiation oncologist:alive|medical oncologist:dead|surgical oncologist (recurrence/secondary cancers):dead",
        "Round 2-num_agents": 3,
        "num_cooperations-panel": 0,
        "decision-Moderator": "('Answer: Alive',)"
    }
}